What Are Cell Factories and How Do They Work?
Discover how biological systems are redesigned at a cellular level to create complex products, from advanced therapeutics to sustainable industrial materials.
Discover how biological systems are redesigned at a cellular level to create complex products, from advanced therapeutics to sustainable industrial materials.
Many everyday products result from microscopic living systems engineered to produce them. These cell factories are composed of microbes like bacteria or yeast, whose natural processes are optimized to generate specific substances. They represent a move from fossil-fuel-based manufacturing toward a bio-based industry, creating everything from medicines and fuels to food ingredients and textiles.
Every living cell has an internal system for producing molecules necessary for survival. This machinery includes metabolic pathways, like biological assembly lines, where enzymes convert a starting material into a final product. Cell factories apply this natural capability by redirecting a cell’s processes to manufacture a desired compound in large quantities, a method known as bioproduction.
Biological systems for manufacturing offer advantages over conventional chemical synthesis. Cells can construct highly complex molecules, such as therapeutic proteins, with a precision difficult to achieve through chemical means. These biological processes occur in water at mild temperatures, reducing energy requirements and the need for harsh solvents.
The principle behind a cell factory is the modification of a cell’s metabolic and regulatory networks. Scientists can engineer a microorganism to use inexpensive and renewable resources as its starting material. The cell’s internal pathways are then optimized to convert this raw material into a high-value product.
The choice of cell type is a determining factor in a cell factory’s design, with different organisms offering unique advantages. Microbial cells, such as the bacterium Escherichia coli and the yeast Saccharomyces cerevisiae, are frequently used. These microorganisms are favored for their rapid growth, simple nutritional needs, and well-understood genetics, making them cost-effective and easier to engineer to produce simpler proteins, enzymes, and biofuels.
A limitation of microbial systems is their inability to perform certain complex modifications to proteins often required for human therapeutics. This is where mammalian cells, particularly Chinese Hamster Ovary (CHO) cells, become important. CHO cells can fold and modify proteins in a manner that resembles human cells, a requirement for producing complex drugs like monoclonal antibodies. The trade-off is that mammalian cells grow more slowly and require more expensive nutrient media.
Beyond microbes and mammalian cells, researchers are exploring other organisms for specialized applications. Plant cells and whole plants are being investigated for their potential to produce vaccines and other proteins on a large scale at a low cost. Insect cells are another alternative, used to produce certain vaccines because they can perform complex protein modifications that microbial cells cannot, while being easier to cultivate than mammalian cells.
Creating a cell factory begins by identifying the gene or set of genes that holds the instructions for making a desired product. Scientists then synthesize this genetic code and introduce it into the host cell. A common method uses plasmids, small, circular pieces of DNA transferred into bacteria or yeast, while deactivated viruses can be vectors for other cell types.
Once the genetic instructions are inside the cell, optimization begins through a field known as metabolic engineering. This involves modifying the cell’s existing metabolic pathways to improve the production of the target molecule. For example, engineers might block pathways that lead to unwanted byproducts, freeing up cellular resources for the desired product and enhancing overall efficiency.
Modern gene-editing tools have significantly advanced the precision of this work. Technologies like CRISPR-Cas9 act as molecular scissors, allowing scientists to make precise edits to a cell’s DNA. This enables them to insert new genes and modify or regulate the activity of existing ones with high accuracy. Creating an effective cell factory involves a cycle of designing genetic changes, building the engineered cell, testing its production, and learning from the results to inform improvements.
Cell factories generate a wide array of products across multiple industries. In medicine, they are responsible for producing therapeutics like insulin, the majority of which is produced in engineered E. coli or yeast cells. They also manufacture vaccines, complex antibodies for treating cancer and autoimmune diseases, and blood clotting factors.
In the industrial sector, cell factories contribute to more sustainable products. They produce enzymes used in laundry detergents to break down stains and in food processing to improve texture. The production of biofuels like ethanol from plant waste is another major application. Innovations include bioplastics and high-performance materials like lab-grown spider silk.
The food and nutrition industry also benefits from cell factory technology. Vitamins, such as B2 and B12, and essential amino acids are produced through microbial fermentation. This technology is also at the forefront of new food frontiers, including producing animal proteins like casein and whey without cows, through a process called precision fermentation.